Home | Welcome to Contract Pharma   
Last Updated Tuesday, March 31 2015


Search Results for 'Financial Report: Thermo Fisher Scientific'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published June 5, 2014
Will share R&D rights to gene editing technology Read More »
By Kristin Brooks
Published January 6, 2014
Gains cell biology and cell therapy R&D technologies Read More »
Published September 4, 2013
Extends long-standing relationship Read More »
Published August 2, 2013
Expands global cell culture and bioprocessing capabilities Read More »
Published July 16, 2012
Will become part of Thermo‚Äôs Specialty Diagnostics Segment Read More »
Published January 6, 2012
Combines product and lab support services for customers Read More »
Published September 15, 2009
Marc N. Casper has been appointed president, chief executive officer and a director of Thermo Fisher Scientific Inc., effective October 15, 2009. Read More »
Published July 26, 2007
Thermo Fisher Scientific, Inc. has entered into an agreement to acquire Qualigens Fine Chemicals, a division of GlaxoSmithKline Pharmaceuticals (GSK India) based in Mumbai. Qualigens is a chemical manufacturer and supplier serving a variety of indust… Read More »
Published May 15, 2007
Sartorius signed a new supply agreement with Thermo Fisher Scientific, Inc. for the non-exclusive reciprocal supply of products for biopharmaceutical process applications between the two companies. Under the agreement, Thermo Fischer Scientific's TC… Read More »
Published December 15, 2006
Thermo Fisher Scientific, Inc. has acquired Cohesive Technologies, Inc., adding in-line sample preparation capabilities that couple with mass spectrometry technology to create end-to-end workflow solutions for drug and other organic molecule analyses… Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On